Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/235615
Type: Artigo de periódico
Title: Metabolic And Structural Bone Disturbances Induced By Hyperlipidic Diet In Mice Treated With Simvastatin.
Author: Soares, Evelise Aline
Novaes, Rômulo Dias
Nakagaki, Wilson Romero
Fernandes, Geraldo José Medeiros
Garcia, José Antônio Dias
Camilli, José Angelo
Abstract: Simvastatin can modulate lipid and bone metabolism. However, information related to the interaction between diet and simvastatin on bone structure and biomechanics is scarce. Thus, this study evaluated the effects of simvastatin on femoral biomechanics and cortical/trabecular bone structure in wild-type mice nourished with a hyperlipidic diet. Three-month-old male wild-type mice (C57BL6 strain) were divided into four groups: (1) group W, nourished with a standard diet; (2) group WH, fed a hyperlipidic diet; (3) group WS, nourished with a standard diet plus oral simvastatin (20 mg/kg/day); and (4) group WHS, fed a hyperlipidic diet plus oral simvastatin (20 mg/kg/day). All animals received only their specific diet and water for 60 days. Blood samples were collected for the analysis of calcium, triglycerides, total cholesterol (TC) and fraction serum levels. Diet manipulation was able to induce a dyslipidaemic status in mice, characterized by triglyceride and TC rise in WH animals. Simvastatin prevented hypercholesterolaemia and reduced TC and LDL serum levels, but did not prevent hypertriglyceridaemia and HDL serum levels in the WHS group. In the WH mice the hyperlipidaemia was associated with reduction in trabecular bone thickness, femur structural and material property alterations. Simvastatin prevented these morphological alterations and minimized femur biomechanical changes in WHS mice. Taken together, the results indicated that the hyperlipidic diet intake acts as a risk factor for bone integrity, generating bones with reduced resistance and more susceptible to fractures, an effect attenuated by simvastatin that is potentially related to the modulatory action of this drug on lipid and bone metabolism.
Subject: Animals
Biomechanical Phenomena
Bone And Bones
Diet, High-fat
Disease Models, Animal
Hydroxymethylglutaryl-coa Reductase Inhibitors
Hyperlipidemias
Male
Mice
Mice, Inbred C57bl
Simvastatin
Citation: International Journal Of Experimental Pathology. v. 96, n. 4, p. 261-268, 2015-Aug.
Rights: embargo
Identifier DOI: 10.1111/iep.12134
Address: http://www.ncbi.nlm.nih.gov/pubmed/?term=26175225
Date Issue: 2015
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_26175225.pdf494.4 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.